Is Agenus Inc. (AGEN) a Buy?

Harnessing the power of the immune system to fight cancer is a big deal and Agenus Inc. (NASDAQ: AGEN)looks like a great way to follow the trend. This stock trades like a small-cap biotech, but a couple of candidates coming through its pipeline could help push annual revenue past the $1 billion mark.

Plus, by this time next year, the company could have half a dozen or so new candidates in clinical trials.